Dow Up 0.35% Nasdaq Down 0.02%

Isis Pharmaceuticals, Inc. (ISIS)

-NMS
35.28 Down 0.43(1.20%) 4:00PM EDT
Prev Close:35.71
Open:35.20
Bid:35.00 x 300
Ask:35.99 x 100
1y Target Est:44.40
Beta:1.63
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:35.05 - 36.15
52wk Range:22.25 - 62.66
Volume:923,894
Avg Vol (3m):2,234,080
Market Cap:4.15B
P/E (ttm):N/A
EPS (ttm):-0.79
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ISIS

Comparison

Symbol% ChgMkt Cap
ISISDown 1.20%4.15B
ENZUp 0.74%239.29M
GILDDown 0.48%152.36B
SRPTDown 2.86%888.85M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):27.83
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.75
Quarterly EPS Est (Sep-14) :-0.17
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-2.08

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Isis Pharmaceuticals, Inc. is engaged in the discovery and development of antisense drugs using novel drug discovery platform. The company’s flagship product includes the KYNAMRO injection, which is an apo-B synthesis inhibitor for patients w... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback